A new cancer treatment more potent than the best-selling cancer drug taxol is
working well in human trials. Epothilone, which comes from soil-dwelling
organisms called myxobacteria, stops cancer cells dividing as taxol does. When a
cell splits in two, elastic protein threads draw the chromosomes apart. But
epothilone binds to these “tubulins” and halts a tumour’s runaway cell division.
“Epothilone stops the chromosomes from being pulled apart,” says Herbie Newell
of the Newcastle University Cancer Research Unit.
More from New Scientist
Explore the latest news, articles and features
91ɫÇéƬ
Less than 4 minutes of vigorous exercise a day could halve your dementia risk
News
91ɫÇéƬ
Parkinson’s may be driven by ‘vicious cycle’ that disrupts brain waste drainage
News
Space
Hubble Space Telescope is falling to Earth – should NASA save it?
News
Space
A robot called GIMLI will explore a lunar cave for a future moon base
91ɫÇéƬ
Popular articles
Trending New Scientist articles